Multiple Sclerosis Discovery Forum

Inspiring Connections

Error message

No active batch.

Most Viewed

Agent based modeling of Treg-Teff cross regulation in relapsing-remitting multiple sclerosis.
Information provision for people with multiple sclerosis.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
The use of complementary and alternative medicine in patients with multiple sclerosis: A longitudinal study.
Statins: From cholesterol-lowering drugs to novel immunomodulators for the treatment of Th17-mediated autoimmune diseases.
Correction to: Multiple sclerosis in the Levant: a regional consensus statement.
Leg spasticity and ambulation in multiple sclerosis.
Multiple sclerosis: Rapid screening for remyelination-promoting drugs using micropillar arrays.
Simvastatin in patients with progressive multiple sclerosis.
MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis.
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
HSV1 and 2 Detection in the CSF of Multiple Sclerosis Patients by Real-time PCR.
Meta-analysis of prevalence.
Risk of fractures in patients with multiple sclerosis: A population-based cohort study.
Cognitive impairment is correlated with reduced quality of life in patients with clinically isolated syndrome.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Multiple deep white matter lesions mimicking multiple sclerosis as an unusual complication of a left atrial myxoma.
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
FDA Drug Safety Communication: FDA investigating rare brain infection in patient taking Gilenya (fingolimod)
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
Contextualized perceptions of movement as a source of expanded insight: People with multiple sclerosis' experience with physiotherapy.
What is needed to keep persons with multiple sclerosis vitamin D-sufficient throughout the year?

Pages